ICICI Prudential Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,462
Closed -$1.67M 157
2025
Q4
$1.67M Sell
9,462
-12,241
-56% -$2M 0.19% 102
2025
Q3
$3.04M Buy
21,703
+415
+2% +$56.1K 0.32% 78
2025
Q2
$2.67M Sell
21,288
-6,941
-25% -$865K 0.33% 77
2025
Q1
$3.86M Sell
28,229
-20
-0.1% -$2.86K 0.5% 62
2024
Q4
$4.32M Sell
28,249
-2,119
-7% -$357K 0.48% 60
2024
Q3
$5.89M Sell
30,368
-9,529
-24% -$1.99M 0.62% 48
2024
Q2
$9.25M Sell
39,897
-1,248
-3% -$271K 1.1% 16
2024
Q1
$8.87M Buy
41,145
+5,156
+14% +$1.21M 1% 30
2023
Q4
$9.31M Buy
35,989
+4,693
+15% +$1.15M 1.08% 20
2023
Q3
$8.04M Buy
31,296
+2,824
+10% +$755K 1.05% 22
2023
Q2
$8.11M Sell
28,472
-2,891
-9% -$861K 1.03% 24
2023
Q1
$8.72M Buy
31,363
+8,177
+35% +$2.26M 1.3% 18
2022
Q4
$6.42M Sell
23,186
-13,021
-36% -$3.68M 0.99% 32
2022
Q3
$9.67M Buy
36,207
+3,827
+12% +$813K 1.51% 13
2022
Q2
$6.64M Buy
32,380
+14
+0% +$2.86K 1.21% 19
2022
Q1
$6.83M Buy
32,366
+3,060
+10% +$665K 0.92% 26
2021
Q4
$7.03M Buy
29,306
+9,162
+45% +$2.36M 0.87% 29
2021
Q3
$5.7M Buy
20,144
+3,166
+19% +$1.04M 0.96% 32
2021
Q2
$5.88M Buy
16,978
+1,439
+9% +$436K 2.21% 19
2021
Q1
$4.29M Hold
15,539
2.2% 24
2020
Q4
$3.81M Buy
+15,539
New +$4.01M 2.59% 16
2017
Q3
$500K Sell
1,596
-100
-6% -$29.6K 2.35% 9
2017
Q2
$491K Hold
1,696
2.16% 23
2017
Q1
$464K Hold
1,696
1.29% 33
2016
Q4
$481K Buy
+1,696
New +$503K 0.51% 28

Other funds holding BIIB

ICICI Prudential Asset Management's BIIB Position: Q1 2026 in Review

ICICI Prudential Asset Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 9,462 shares — an estimated $1.67M sold.

ICICI Prudential Asset Management first reported a position in BIIB in Q4 2016 and held it in 25 quarters. The position peaked at $9.67M in Q3 2022. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • ICICI Prudential Asset Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • ICICI Prudential Asset Management sold 9,462 Biogen shares in Q1 2026, an estimated $1.67M.
  • ICICI Prudential Asset Management first reported a position in Biogen in Q4 2016 and held it in 25 quarters.
  • ICICI Prudential Asset Management's Biogen position peaked at $9.67M in Q3 2022.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on ICICI Prudential Asset Management's 13F filing for Q1 2026, filed 11 May 2026.